Navigation Links
The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research
Date:8/27/2008

Award Winning Research Team Makes Crucial Breakthrough in Battle to Prevent

Onset of Parkinson's Disease

CHICAGO, Aug. 27 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson's disease.

The researchers have genetically produced the first ever mouse model with the type of brain degeneration, or nerve cell loss, seen in Lewy body disease and Parkinson's disease, which could lead to more targeted drugs to treat the degenerative conditions.

The study has been carried out by Professor John Mayer and Dr Lynn Bedford in the University's School of Biomedical Sciences, in collaboration with Professor Jim Lowe in the School of Molecular Medical Sciences.

Professor John Mayer said: "Current drugs given to people with Lewy body and Parkinson's disease simply treat the symptoms. This model is the first platform to understand how the brain cell deterioration takes place. We will use this model to identify targets for new drugs to slow or prevent the disease."

Lewy body disease, also known as dementia with Lewy bodies (DLB) shares characteristics with both Alzheimer's and Parkinson's diseases. The number of people with dementia is forecast to double within a generation.

Dr Kieran Breen, Director of Research and Development at the Parkinson's Disease Society, added: "The formation of Lewy bodies is a key event in the development of nerve cell death associated with Parkinson's disease. Understanding how these are formed will help us to figure out what happens when nerve cells die in Parkinson's and from this to develop therapies that will ultimately provide a cure for the condition."

"Universities in the Midlands continue to set the bar in innovation and discovery," said Vern Sebby, President and CEO of British Mi
'/>"/>

SOURCE British Midlands Development Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
2. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
3. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
4. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
5. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
6. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
7. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
8. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
9. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
10. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
11. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...all/--ERT(Nasdaq: ERES ),announcedtodaythatDr.Mich...Schneck,theCompany,sExecutiveVicePresidentandCFO,a...lthCareConferenceat1:30PMESTonDecember1,2009inNewY...hepresentationbyvisitingtheCompany,scorporatewebsi...edat http://www.corporate-ir.net/ireye/conflobby.z...
(Date:11/25/2009)...TheFDAgrantedtraditionalapprovalforINTELENCE®...ptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspeci...swhoareexperiencingvirologicfailurewithHIV-1strain...ts.Thetraditionalapprovalisbasedon48-weekdatafromt...urrentlymarketedintheU.S.byTibotecTherapeutics,adi...
(Date:11/25/2009)...e/--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmeric...hatitreceivedtheEnvironmentalResponsibilityandSust...mmit,sponsoredbytheCaliforniaManufacturersandTechn...ssociation(IEA)andtheChemicalIndustryCouncilofCali...sawardavailablefromallthreeorganizationsandgainssu...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Tattoo Removal on the Fastest U S Marine 62003 1Tattoo Removal on the Fastest U S Marine 62003 2FloatScope A New Device for Self Viewing Eye Floaters 62001 1FloatScope A New Device for Self Viewing Eye Floaters 62001 2Cell Therapeutics Inc 28CTI 29 to Present at 21st Annual Piper Jaffray Health Care Conference 14951 1
...to Reduced Premature Births, WATSONVILLE, Calif.,...study that shows folic acid supplements greatly,re...ral health officials,say not enough women are taki... to remember to take vitamins, but women (and,men)... visit their,supermarket,s produce aisle or farmer...
.... 5 Joseph F. Finn, Jr.,CPA, the Assignee for the...oday that The Committee for Orphan Drug Products o... Orphan Drug Designation for M40403 for the,preven...r patients,receiving radiotherapy., The developme...ead and,neck cancers is the major reason for poor ...
Other Medicine Technology:Folate in Strawberries May Contribute to Healthy Pregnancy 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 2ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication 3
(Date:11/27/2009)... Three new interactive anatomy education apps...ns expand health sciences learning opportunities f... Durham, NC (Vocus) November 27, 2009 -- Modalit...W), a division of Wolters Kluwer Health, today ann...tion apps on the App Store. Clemente’s Anato...
(Date:11/26/2009)...ering drug tetrathiomolybdate (TM) has been shown ...son disease, a disease caused by an overload of co... known. Very little, however, is known about how t...udy led by Northwestern University researchers now...ional structure of TM bound to copper-loaded metal...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center,...s , is one of a growing number of physicians who a...sites to connect with individuals who are interest...id obesity. Dr. Kim is utilizing Facebook to share... practice with the community. , ...
(Date:11/25/2009)...Nov.25/PRNewswire-USNewswire/--Whenmostpeopleheart...torcanalsogivepatientsthehelptheyneed.TMJstandsfor...ndible)contacts/connectswithyourskull(temporalbone...functionarepainwithchewing,clickingorpoppingofthej...onincluding:headaches,fatigue,sleepdisturbances,ir...
(Date:11/25/2009)...25/PRNewswire/-SentinelleMedicalInc.,aleadingmanuf...twarelaunchesasuiteofnewleadingedgeclinicalapplica...tthisyear,sRadiologicalSocietyofNorthAmerica(RSNA)...,HallA).Theapplicationsleveragetheuniquehighqualit...gcoilsandsupportmultipleimagingmodalitiesformulti-...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...es compiled by National AIDS Control Organisation ...lection strategy, have shown that an estimated// 5...his clearly indicates that the number of people in... deadly virus. It is estimated 38% of females and ...
...tructural difference in the brain can explain why ...ond in unique ways to the effects// of certain pai...esearchers at Georgia State University and the Atl...rences occur in humans as well. The results of thi...
...zens over the poisonous vegetables found in local ...tary registration system// for local farms. Additi...equired to set up a comprehensive tracking system ...hat helped alleviate the citizens' anxiety over th...
...pears in the March 2006 online issue of BMC Public...the armed forces who served in Vietnam and the inc...n exists since a defoliate called Agent Orange has... men with CaP from Western Australia participated ...
...ew Zealander says that he was forced to take drama...endent diabetic wife received her medications. // ...'s anti-nausea drug only after he refused to take ...Bay hospital refused to provide enough of the drug...
... one of the leading company which manufactures con... it caused serious eye infections in some users. /...tion (FDA) started to inspect Bausch & Lomb facili...usch & Lomb stopped shipping the solution, called ...
Other Medicine News:Health News:HIV/AIDS On The Rise In India 2Health News:Gender Difference In Pain Experience Explained By Brain Diversity 2
INSIGNIA Ultra SR
...88 active-fixation leads are among the world's thi...g the unsurpassed handling advantages, performance...ne of active-fixation leads. Implantable with a 7 ...dril SDX lead is designed to lower the incidence o...
Veriteq's Refrigerator and Freezer Monitoring System
Aegis Checkpoint Temperature Reporting and Alarm System
Medicine Products: